SEC Form 4 · accession 0001128732-17-000022
Medicine Man Technologies, Inc. · MDCL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Dickman
Director
Period of report
Jun 7, 2017
Accepted (ET)
Jul 17, 2017 · 9:13 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001622879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 7, 2017 | A | 125,000 | $0.93 | A | 205,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Warrants | $1.445 | Jun 7, 2017 | A | 250,000 | A | Jun 7, 2017 | Dec 31, 2019 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1Reporting Person received shares of restricted Common Stock pursuant to the terms of the Issuer's 2017 Equity Incentive Plan.